Last Updated on July 1, 2021 by The Health Master
Global pharma major Lupin Limited announced the launch of emtricitabine and tenofovir disoproxil fumarate tablets 200 mg/300 mg, having received an approval from the United States Food and Drug Administration (USFDA).
Emtricitabine and tenofovir disoproxil fumarate tablets 200 mg/300 mg, are the generic equivalent of Truvada tablets 200 mg/300 mg, of Gilead Sciences, Inc., and indicated in combination with other antiretroviral agents for the treatment of HIV-1 infection.
It is also used for pre-exposure prophylaxis (PrEP) to reduce the risk of sexually acquired HIV-1 infection.
Emtricitabine and tenofovir disoproxil fumarate tablets had estimated annual sales of US$ 2.1 billion in the US, according to IQVIA MAT March 2021.
Dr Reddy’s Lab commercially launches 2DG
Dr. Reddy’s Labs launches Icosapent Ethyl Capsules
Cadila Pharma launches Posaconazole to treat fungal diseases
Cipla launches Vitamin C Chewable Tablets with Gold Supplement
Glenmark launches drug to treat Pulmonary disease in UK
Alkem launches Drug for Epilepsy treatment in India
Latest Notifications: DMROA (Drugs and Magic Remedies Act)
Copyright – An article (Part-1)
Copyright – An article (Part-2)
Pharma Industry: On Ban on Methylcobalamin Pan India
40 Pharma Firms showed interest in anti Covid drug: DRDO
15,000 StayHappi Pharmacy Stores to be opened
For informative videos by The Health Master, click on the below YouTube icon:
For informative videos on Medical Store / Pharmacy, click on the below YouTube icon:
For informative videos on the news regarding Pharma / Medical Devices / Cosmetics / Homoeopathy etc., click on the below YouTube icon:
For informative videos on consumer awareness, click on the below YouTube icon:
